<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>2476840</identifier>
<setSpec>0014-2565</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Domínguez Muñoz, J E</dc:author>
<dc:author>de la Morena Fernández, J</dc:author>
<dc:author>Carballo Alvarez, L F</dc:author>
<dc:description xml:lang="en">The understanding of the causes for hyperamylasemia is of great importance when focusing on the differential diagnosis of acute pancreatitis. Among the causes for hyperamylasemia, special interest is given to macroamylasemia not only because it is poorly understood, but also because we are lacking national studies. In this disorder, the amyl binds to another serum substance, varying from one patient to another, and forms a macromolecular complex. The biochemical characteristics of clinical interest as well as its prevalence are discussed. Its etiopathogenesis and clinical implications are unknown, requiring different methods for its detection that will give better efficacy and reproducibility.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:date>1989 May </dc:date>
<dc:title xml:lang="es">Macroamilasemia: actualización e importancia clínica.</dc:title>
<dc:title xml:lang="en">[Macroamylasemia: its current and clinical importance].</dc:title>
<dc:publisher>Revista clinica espanola</dc:publisher>
</metadata>
</record>
</pubmed-document>
